Walpar Nutritions Limited (NSE:WALPAR)

India flag India · Delayed Price · Currency is INR
45.50
-2.35 (-4.91%)
At close: Jan 29, 2026
Market Cap427.27M -6.3%
Revenue (ttm)757.46M +17.7%
Net Income23.31M -5.7%
EPS2.49 -6.5%
Shares Out9.39M
PE Ratio18.31
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,000
Average Volume5,200
Open45.50
Previous Close47.85
Day's Range45.50 - 45.50
52-Week Range37.70 - 53.30
Beta-0.51
RSI52.79
Earnings DateFeb 12, 2026

About Walpar Nutritions

Walpar Nutritions Limited manufactures and trades pharmaceutical, nutraceutical, herbal, and ayurvedic commodities in India. The company offers G-Flora, a probiotic blend for gut health and immunity; Inosia-F, an inositol supplement; Inovam Plus, a multivitamin; Ironica-CR, controlled-release iron supplement; Myobest, muscle support formula; Ovality, ovarian health support; Ovanyx-F, a female reproductive health supplement; Ovacon-F, women's fertility support; PCOS Care Forte, a PCOS support; Procive-F, female fertility enhancement supplement; ... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country India
Stock Exchange National Stock Exchange of India
Ticker Symbol WALPAR
Full Company Profile

Financial Performance

In fiscal year 2025, Walpar Nutritions's revenue was 719.60 million, an increase of 14.93% compared to the previous year's 626.13 million. Earnings were 23.24 million, an increase of 46.92%.

Financial Statements